PENGARUH PROFITABILITAS, LEVERAGE, GROWTH OPPORTUNITY, DAN UKURAN PERUSAHAAN TERHADAP NILAI PERUSAHAAN

Abstract

This research aimed to find out the effect of profitability (Return on Equity), leverage (Debt to Asset Ratio), growth opportunity (growth ratio), and firm size (SIZE) on the firm value (Price Book Value) of pharmaceutical companies (healthcare) listed on the Indonesia Stock Exchange (IDX) during 5 years (2017-2021). Furthermore, the data collection technique used purposive sampling. In line with that, there were 55 data samples which based on the determined criteria. The research was quantitative. Moreover, the data were in a form of financial statements from pharmaceutical companies (healthcare) during 2017-2021 taken from the Investment Gallery of Indonesia Stock Exchange (GIBEI) STIESIA Surabaya. Additionally, the data analysis technique used multiple linear regression with SPSS (Statistical Product and Service Solution). The result showed that profitability had a positive and significant effect on the firm value. However, leverage did not affect the firm value. Likewise, growth opportunity did not affect the firm value. On the other hand, the firm size had a positive and significant effect on the firm value.